Sensipar (cinacalcet), a new drug for dialysis patients

Health Canada has just approved Sensipar (cinacalcet), a new drug for dialysis patients.

Chronic kidney disease leads to high serum phosphate...low vitamin D levels...and low serum calcium.

This signals the parathyroid glands to pump out more parathyroid hormone.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote